| 1998 |
Caspase-8 cleaves BID, and the C-terminal fragment (tBid) translocates to mitochondria where it triggers cytochrome c release; immunodepletion of BID eliminated cytochrome c releasing activity; a BH3 domain mutation diminished activity; Bcl2 antagonized tBid activity |
Protein purification, peptide mass fingerprinting, in vitro caspase cleavage assay, immunodepletion, site-directed mutagenesis, cell-free cytochrome c release assay |
Cell |
High |
9727491
|
| 1996 |
BID is a BH3-only protein that heterodimerizes with both BAX and BCL-2 via its BH3 domain; an intact BH3 domain is required to bind the BH1 domain of BCL-2 or BAX; BH3 mutagenesis dissociated binding from death-promoting activity; BID expression induces ICE-like proteases and apoptosis |
Interactive (yeast two-hybrid) cloning, site-directed mutagenesis, co-immunoprecipitation, cell death assays |
Genes & development |
High |
8918887
|
| 2001 |
BID is phosphorylated by casein kinase I (CKI) and casein kinase II (CKII); phosphorylated BID is insensitive to caspase-8 cleavage in vitro; inhibition of CKI/CKII accelerated Fas-mediated apoptosis and BID cleavage; a non-phosphorylatable BID mutant was more toxic than wild-type |
In vitro kinase assay, site-directed mutagenesis, pharmacological kinase inhibition, Fas-mediated apoptosis assays |
Molecular cell |
High |
11583622
|
| 2005 |
BID is phosphorylated by ATM kinase following DNA double-strand breaks on two ATM consensus sites; BID-deficient cells fail to accumulate in S phase after etoposide treatment; a non-phosphorylatable BID mutant did not restore S phase arrest and increased sensitivity to etoposide-induced apoptosis; BID partially localizes to the nucleus in healthy cells |
Phosphorylation mapping, ATM kinase assay, Bid-/- cell reconstitution with wild-type vs. phospho-mutant BID, cell cycle analysis, nuclear fractionation |
Cell |
High |
16122425 16122426
|
| 2005 |
PACS-2 translocates BID to mitochondria in response to apoptotic inducers, initiating tBid formation, cytochrome c release, and caspase-3 activation; depletion of PACS-2 prevents BID-mediated apoptosis |
siRNA knockdown, subcellular fractionation, Western blot for tBid/cytochrome c/caspase-3, live-cell imaging of mitochondria-ER contacts |
The EMBO journal |
Medium |
15692567
|
| 2010 |
BID, BIM, and PUMA are essential activators of BAX and BAK; triple knockout of Bid/Bim/Puma phenocopies Bax/Bak double knockout (persistent interdigital webs, imperforate vaginas) and prevents BAX/BAK homo-oligomerization and cytochrome c release in neurons and T lymphocytes |
Triple-knockout mouse genetics, epistasis analysis, cytochrome c release assay, BAX/BAK oligomerization assay |
Science |
High |
21127253
|
| 2013 |
NMR solution structure of the human BID BH3–BAK complex identified the activation site at the canonical BH3-binding groove of BAK; BAK BH1 groove mutations prevented MOMP but not BID binding; BAK BH3 mutations allowed BID binding but blocked oligomerization; BID follows a 'hit-and-run' mechanism dissociating from the trigger site to allow BAK oligomerization; NOXA and BAD are predicted to clash with the trigger site and are not activators of BAK |
NMR structure determination, site-directed mutagenesis of BAK BH1 and BH3 domains, MOMP assay, binding assay |
Nature structural & molecular biology |
High |
23604079
|
| 2013 |
BID preferentially activates BAK while BIM preferentially activates BAX; cells lacking BAK are relatively resistant to agents requiring BID activation (topoisomerase inhibitors, TRAIL) |
BH3 profiling, BAK/BAX knockout cell lines, apoptosis assays, clinical correlation |
Molecular cell |
High |
24074954
|
| 2002 |
Calpain cleaves BID between Gly70 and Arg71 in cisplatin-treated cells, yielding a 14-kDa fragment; calpain-cleaved BID induces cytochrome c release from isolated mitochondria; calpain inhibitors but not caspase or cathepsin L inhibitors prevented BID cleavage |
In vitro calpain cleavage of recombinant BID, cleavage site mapping, isolated mitochondria cytochrome c release assay, pharmacological inhibitor panel |
Molecular and cellular biology |
High |
11940658
|
| 2000 |
Granzyme B cleaves cytosolic BID to produce truncated BID, which is the sole cytosolic protein responsible for GrB-induced cytochrome c release in a cell-free system; GrB also acts directly on mitochondria to open the permeability transition pore independently of cytosolic proteins |
Cell-free in vitro system, immunodepletion, recombinant protein assays, mitochondrial membrane potential measurement |
The Journal of biological chemistry |
High |
11114298
|
| 2004 |
Bid-deficient cells from multiple tissues are resistant to granzyme B-induced cell death; cytochrome c remains in mitochondria of Bid-deficient cells treated with granzyme B; surviving Bid-deficient cells proliferate normally |
Bid-/- mouse-derived primary cells, granzyme B treatment, cytochrome c localization by fractionation, cell viability and proliferation assays |
The Journal of biological chemistry |
High |
15574417
|
| 2008 |
Lysosomal cysteine cathepsins (B, L, S, K, H) cleave BID in vitro; cathepsin-mediated BID cleavage triggers the mitochondrial apoptosis pathway; E-64d (cysteine protease inhibitor) prevented BID cleavage and apoptosis |
In vitro protease cleavage assays with purified cathepsins and recombinant BID, pharmacological inhibitor studies, cell death assays |
The Journal of biological chemistry |
High |
18469004
|
| 2002 |
BID is a p53 transcriptional target; the human and mouse BID genomic loci contain p53-binding DNA response elements that bind p53 and mediate p53-dependent transactivation; BID-null MEFs are more resistant to adriamycin and 5-fluorouracil |
Reporter gene assay with p53 response elements, chromatin immunoprecipitation-like binding assay, BID-null MEF apoptosis assays |
Nature cell biology |
Medium |
12402042
|
| 2011 |
BID interacts with NOD1, NOD2, and the IKK complex, impacting NF-κB and ERK signaling; BID-deficient colonocytes and macrophages are markedly defective in cytokine production in response to NOD activation; Bid-/- mice are unresponsive to NOD agonists in experimental colitis |
Genome-wide RNAi screen, co-immunoprecipitation of BID with NOD1/NOD2/IKK, Bid-/- macrophage cytokine assays, in vivo colitis model |
Nature |
High |
21552281
|
| 2000 |
Recombinant BID and Bax cause complete cytochrome c loss from isolated mitochondria in vitro while preserving inner membrane ultrastructure and protein import function; BID and BAX act only on the outer mitochondrial membrane; inner membrane lesions during apoptosis are secondary caspase-dependent events |
Isolated mitochondria in vitro assay, electron microscopy of ultrastructure, mitochondrial protein import assay, caspase inhibition experiments |
The Journal of cell biology |
High |
10973993
|
| 2000 |
BID-induced mitochondrial membrane permeabilization can be inhibited by PTPC inhibitors (cyclosporin A, bongkrekic acid); full-length BID preferentially permeabilizes membranes containing both ANT and BAX; tBid acts on membranes containing ANT alone, suggesting functional interaction with ANT (adenine nucleotide translocase) |
Intact cell microinjection, isolated mitochondria assay, proteoliposome reconstitution, planar bilayer electrophysiology |
Oncogene |
Medium |
11175349
|
| 2002 |
tBid requires interaction with BAX and the BAX C-terminal transmembrane domain to induce ionic channel formation in liposomes; cut BID alone cannot induce BAX oligomerization in liposomes; an additional mitochondrial factor is required for BAX oligomerization |
Liposome reconstitution, planar bilayer electrophysiology, gel filtration, recombinant protein interaction assays |
The Biochemical journal |
Medium |
11964155
|
| 2016 |
Cleavage by caspase-8 (not effector caspases) is the primary event activating BID during TRAIL-induced apoptosis; additionally, association of tBid with the outer mitochondrial membrane via helices α6 and α7 is required for full apoptotic activity; a tBid mutant lacking these helices has diminished activity despite an intact BH3 domain |
CRISPR/Cas9 BID-KO and BID/BAX/BAK TKO cells, reconstitution with wild-type and caspase-resistant/BH3-defective/helix-deletion mutants, TRAIL apoptosis assay |
The Journal of biological chemistry |
High |
27053107
|
| 2011 |
BID controls BAX activation in AIF-mediated caspase-independent necroptosis; BID is processed by calpains into tBid (non-cleavable BID-G70A or BID-Δ68-71 abolishes BAX activation); tBid localizes to mitochondria to facilitate BAX activation and programmed necrotic death |
Bid-/- and calpain-resistant BID mutant MEFs, BAX activation assay, necroptosis (MNNG) model, reintroduction of wild-type vs. mutant BID |
Cell death and differentiation |
High |
21738214
|
| 2012 |
ATM-mediated BID phosphorylation maintains quiescence of haematopoietic stem cells (HSCs); loss of BID phosphorylation leads to escape from quiescence, HSC pool exhaustion, and reduced repopulating potential; BID phosphorylation protects HSCs from irradiation by regulating oxidative stress; loss of phosphorylation or ATM knockout increases mitochondrial BID correlating with increased mitochondrial ROS |
Knock-in phospho-mutant BID mice, HSC quiescence assays (BrdU), competitive reconstitution assays, ROS measurement, irradiation survival |
Nature cell biology |
High |
22446738
|
| 2011 |
BID associates with RPA70 N-terminal basic cleft; BID stimulates association of RPA with ATR-ATRIP complex; disruption of BID-RPA interaction impairs ATR-ATRIP chromatin association, CHK1 activation, and recovery of DNA replication following hydroxyurea |
Co-immunoprecipitation, NMR mapping of BID-RPA70 interaction, BID mutants disrupting RPA binding, chromatin fractionation, CHK1 phosphorylation assay, DNA replication recovery assay |
Molecular and cellular biology |
High |
21859891
|
| 2010 |
BID functions at the level of the ATR damage sensor complex following replicative stress; BID is found in nuclear foci with RPA and associates with ATR/ATRIP/RPA complex; BID-deficient cells show reduced ATR/ATRIP chromatin loading, reduced CHK1 activation, and impaired recovery of DNA synthesis |
Nuclear foci colocalization, co-immunoprecipitation of BID with ATR/ATRIP/RPA, Bid-/- cell chromatin fractionation, CHK1 phosphorylation assay |
Cell death and differentiation |
High |
21113148
|
| 2005 |
Humanin (HN) peptide binds purified BID and tBid in vitro; HN blocks tBid-induced cytochrome c and SMAC release from isolated mitochondria; HN inhibits tBid-induced BAX and BAK oligomerization in mitochondrial membranes; inactive HN mutants fail to bind BID or block these activities |
In vitro binding assay with purified proteins, isolated mitochondria cytochrome c/SMAC release assay, chemical cross-linking/gel filtration for oligomerization, gene transfection |
The Journal of biological chemistry |
Medium |
15661737
|
| 2004 |
Membrane-insertion analysis shows that the α6 helix of tBid inserts into membranes only as part of the α6-α7 hairpin (not individually), indicating synergistic hairpin insertion into mitochondrial membrane is required for function |
Glycosylation mapping of chimeric single-helix segments in a model membrane insertion system |
Biochemistry |
Medium |
15323553
|
| 2021 |
Stepwise activation of cBid at real mitochondrial membranes: upon mitochondrial binding, cBid reorganizes to expose the BH3 domain while maintaining overall structural integrity; membrane-bound cBid associates with MTCH2 and remains primed until interacting with BAX, which triggers cBid fragmentation, large conformational changes, and BAX-mediated MOMP |
Spin-label ESR spectroscopy, site-directed PEGylation at real mitochondrial membranes, co-immunoprecipitation with MTCH2 |
Cell death and differentiation |
High |
33462413
|
| 2016 |
In live cells, BID adopts an extended conformation at the mitochondrial outer membrane critical for its association with the membrane and for intermolecular contacts within BID oligomers; direct intermolecular FRET contacts between BID and BAX were observed in live cells, confirming BID as a component of the BID-BAX permeabilization network |
Confocal FRET microscopy in live cells, FRET efficiency measurement, conformational analysis |
Cell death & disease |
Medium |
27763642
|
| 2003 |
Three novel BID isoforms are generated by alternative splicing: BidS (lacks BH3 domain, inhibits tBid pro-apoptotic effects and Fas-mediated apoptosis), BidEL (induces apoptosis), and BidES (induces apoptosis but partially inhibits tBid); expression of these isoforms is regulated during granulocyte maturation and they differ in subcellular localization |
RT-PCR/gene structure analysis, endogenous protein detection, cell death assays, subcellular localization |
The Journal of biological chemistry |
Medium |
14583606
|
| 2017 |
BID translocates to mitochondria during erastin-induced ferroptosis; CRISPR/Cas9 Bid knockout preserves mitochondrial integrity and function, and mediates neuroprotection against ferroptosis and oxytosis; BID inhibitor BI-6c9 inhibited ferroptosis; ferroptosis inhibitors (ferrostatin-1, liproxstatin-1) prevented BID-dependent mitochondrial dysfunction |
CRISPR/Cas9 BID knockout, mitochondrial membrane potential measurement, ATP assay, mitochondrial fragmentation imaging, pharmacological inhibitors |
Redox biology |
Medium |
28384611
|
| 2020 |
Caspase-1 directly cleaves BID to generate tBid; in GSDMD-deficient cells, tBid-induced MOMP drives SMAC release to relieve IAP inhibition of caspase-3, enabling rapid secondary necrosis; caspase-1-driven activation of caspase-8/-9 and Bid cleavage act synergistically |
GSDMD-/- and GSDMD/BID double-KO cells, caspase activation assays, SMAC release measurement, caspase-1 cleavage assay |
Life science alliance |
Medium |
32345661
|
| 2008 |
BID translocation to mitochondria precedes AIF release; BID-mediated mitochondrial AIF release causes rapid nuclear translocation and caspase-independent neuronal death; BID siRNA and BID inhibitor prevented AIF nuclear translocation and cell death; tBid-induced death was inhibited by AIF siRNA, establishing AIF as the main downstream effector of BID in glutamate-induced neuronal death |
Fluorescence video microscopy, BID siRNA, small molecule BID inhibitor, AIF siRNA, caspase-3 inhibitor comparison |
Cell death and differentiation |
Medium |
18535584
|
| 2002 |
BID sequence has significant similarity to plant lipid transfer proteins; isolated BID shows lipid transfer activity higher than plant LTPs; lysolipids alter BID association with mitochondria and stimulate BID-induced cytochrome c release; BID enhances incorporation of fluorescent lysolipids into mitochondria |
Sequence analysis, in vitro lipid transfer assay, isolated mitochondria cytochrome c release assay with exogenous lipids, fluorescent lipid incorporation assay |
Biochimica et biophysica acta |
Medium |
11997142
|
| 2010 |
Activity of protein kinase CK2 temporally uncouples caspase-8 activation from BID cleavage during TRAIL-induced apoptosis; CK2 inhibition (DRB) or dominant-negative CK2α largely eliminated the lag time between caspase-8 activation and BID cleavage in individual cells |
Single-cell FRET probes for caspase-8 (IETD) and full-length BID, CK2 inhibitor and dominant-negative expression, time-lapse microscopy |
Journal of cell science |
Medium |
20356928
|
| 2006 |
PLZF transcription factor binds a high-affinity site upstream of the BID transcriptional start site (EMSA) and represses BID expression; PLZF-expressing Jurkat cells show retarded mitochondrial membrane potential loss and resistance to apoptosis |
Differential expression screen, EMSA for PLZF binding to BID promoter, inducible PLZF expression, annexin V/TUNEL apoptosis assays |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
14769944
|
| 2013 |
Caspase-cleaved arrestin-2-(1-380) directly binds tBID and doubles tBid-induced cytochrome c release from isolated mitochondria; arrestin-2 pro-apoptotic action requires BID: it does not facilitate apoptosis in BID KO cells, and rescue of BID expression restores activity |
Co-immunoprecipitation of arrestin-2 fragment with tBID, isolated mitochondria cytochrome c release assay, BID-/- cells with reconstitution, caspase-3 activity assay |
Cell death and differentiation |
Medium |
24141717
|
| 2000 |
In some cell types, tBID induces BAX insertion into mitochondria in vivo and in vitro; tBID relieves inhibition of the BAX transmembrane signal-anchor by the N-terminal domain; however, Bid-null MEFs support BAX insertion into mitochondria in response to TNFα or E1A without BID, demonstrating a parallel BID-independent pathway for BAX membrane insertion in which cytochrome c release is uncoupled from BAX insertion |
tBid reconstitution in vitro, Bid-null MEF apoptosis and BAX insertion assays, confocal BAX localization |
Cell death and differentiation |
Medium |
11139284
|
| 2006 |
Human granzyme B efficiently cleaves human or mouse BID, but mouse granzyme B is highly resistant to cleaving BID, indicating the BID pathway is not a major primary mediator of mouse granzyme B cytotoxicity; substrate specificity differences mapped to tetrapeptide recognition |
Substrate specificity profiling, in vitro cleavage assay with human vs. mouse granzyme B and BID substrates |
The Journal of biological chemistry |
Medium |
17179148
|
| 2004 |
BID cleavage at Asp60 and/or Asp75 (caspase-8/granzyme B target residues) is required for mitochondrial permeabilization and apoptosis induced by etoposide and gamma-radiation in p53-mutant T leukemic cells; this activation is independent of death receptor or mitochondrial inducer caspase activation; caspase-2 knockdown did not prevent BID activation by DNA damage |
Dominant-negative caspase constructs, CrmA expression, siRNA against caspase-2, BID cleavage site mapping, mitochondrial permeabilization assay |
The Journal of biological chemistry |
Medium |
15117953
|